ES71
TEAS SECTION 71 RECEIVED
30/07/2026
Voltar para busca
Dado oficial do USPTO
HEMOLUMI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
30/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 10
Data de depósito
11/11/2019
Data de registro
01/06/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
01/06/2021
Última transação
30/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
Guangdong, CN
Examinador
LAM, HAI-LY HUYNH
Unidade examinadora
N10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Representantes
Alex D. Patel Patel IP, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Diagnostic reagents for medical purposes; reagents for medical purposes; chemical preparations for medical purposesfor blood coagulation and anticoagulationfibrinolysis and anti-fibrinolysis functional analysisfor quantitative or qualitative detection of various analytes in human serumplasma or other body fluids; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical purposes; dietetic substances adapted for medical usedietetic sugar for medical usedietetic infusions for medical use; air purifying preparations; diagnostic reagents for veterinary purposes
Classe 9
Computer programsrecordedfor controlling the operation of blood coagulation analyzing apparatus and instruments; computer operating programsrecorded; computer peripheral devices; recorded computer software for data analysis and processing; data processing equipmentcouplers; interfaces for computers; downloadable computer programs for monitoring data from medical imaging apparatus; downloadable electronic publicationsbookshand-outsworkbooks in the field of business; downloadable computer software applications for use in blood coagulation analyzing apparatus and instruments controlfor controlling mobile phonesportable media playershandheld computersfor remotely controlling other PC softwarefor database management and electronic storage of data; computer software applicationsdownloadablesoftware for use in database management and electronic storage of data
Classe 10
Medical apparatus and instrumentsautomatic blood analyzers featuring a blood coagulation module and immunoassay module; diagnostic apparatus for medical purposesblood coagulation analyzing apparatus and instruments; blood testing apparatus; apparatus for blood analysis; testing apparatus for medical purposesblood testing apparatus; special containers especially adapted for the disposal of medical devicessyringes and other contaminated medical waste; containers especially made for medical waste; medical ultrasound equipment; suture materials; dental apparatus and instrumentsdental drillsdental picksdental excavators
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
22/07/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
22/07/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22/07/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22/07/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
22/07/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
22/07/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/06/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
29/10/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
17/09/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
17/09/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/09/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
01/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/03/2021
PUBO
PUBLISHED FOR OPPOSITION
16/03/2021
GPNX
NOTIFICATION PROCESSED BY IB
14/03/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
24/02/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
24/02/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/02/2021
ALIE
ASSIGNED TO LIE
09/02/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/02/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
02/02/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/02/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
02/02/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/01/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/01/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
19/08/2020
GNFR
FINAL REFUSAL E-MAILED
19/08/2020
CNFR
FINAL REFUSAL WRITTEN
19/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/07/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/07/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/07/2020
RFNT
REFUSAL PROCESSED BY IB
27/03/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/03/2020
RFRR
REFUSAL PROCESSED BY MPU
09/03/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
19/02/2020
CNRT
NON-FINAL ACTION WRITTEN
18/02/2020
DOCK
ASSIGNED TO EXAMINER
13/02/2020
MAFR
APPLICATION FILING RECEIPT MAILED
28/01/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/01/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
23/01/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HEMOLUMI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.